213 related articles for article (PubMed ID: 8320132)
1. Inhibition of allostimulated HLA-DQ and DP-specific T cells by staphylococcal enterotoxin A.
Masewicz S; Ledbetter JA; Martin P; Mickelson E; Hansen JA; Odum N
Hum Immunol; 1993 Mar; 36(3):142-8. PubMed ID: 8320132
[TBL] [Abstract][Full Text] [Related]
2. Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules.
Scholl PR; Diez A; Karr R; Sekaly RP; Trowsdale J; Geha RS
J Immunol; 1990 Jan; 144(1):226-30. PubMed ID: 2404064
[TBL] [Abstract][Full Text] [Related]
3. Staphylococcal enterotoxin B and toxic shock syndrome toxin-1 bind to distinct sites on HLA-DR and HLA-DQ molecules.
Scholl PR; Diez A; Geha RS
J Immunol; 1989 Oct; 143(8):2583-8. PubMed ID: 2551962
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcal enterotoxin-mediated human T-T cell interactions.
Koning F; Rust C
J Immunol; 1992 Jul; 149(1):317-22. PubMed ID: 1535087
[TBL] [Abstract][Full Text] [Related]
5. Staphylococcal toxins bind to different sites on HLA-DR.
Chintagumpala MM; Mollick JA; Rich RR
J Immunol; 1991 Dec; 147(11):3876-81. PubMed ID: 1940373
[TBL] [Abstract][Full Text] [Related]
6. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
Lamphear JG; Stevens KR; Rich RR
J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
[TBL] [Abstract][Full Text] [Related]
7. Receptors for toxic shock syndrome toxin-1 and staphylococcal enterotoxin A on human blood monocytes.
See RH; Krystal G; Chow AW
Can J Microbiol; 1992 Sep; 38(9):937-44. PubMed ID: 1281444
[TBL] [Abstract][Full Text] [Related]
8. Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules.
Scholl PR; Sekaly RP; Diez A; Glimcher LH; Geha RS
Eur J Immunol; 1990 Sep; 20(9):1911-6. PubMed ID: 2209697
[TBL] [Abstract][Full Text] [Related]
9. Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor.
Dohlsten M; Hedlund G; Segren S; Lando PA; Herrmann T; Kelly AP; Kalland T
Eur J Immunol; 1991 May; 21(5):1229-33. PubMed ID: 1645269
[TBL] [Abstract][Full Text] [Related]
10. Superantigens: interaction of staphylococcal enterotoxins with MHC class II molecules.
Rich RR; Mollick JA; Cook RG
Trans Am Clin Climatol Assoc; 1990; 101():195-204; discussion 204-6. PubMed ID: 2577245
[TBL] [Abstract][Full Text] [Related]
11. Not every superantigen induces tolerance in vivo.
Ochi A; Yuh K; Migita K
Semin Immunol; 1993 Feb; 5(1):57-63. PubMed ID: 8467096
[TBL] [Abstract][Full Text] [Related]
12. Relative activities of distinct isotypes of murine and human major histocompatibility complex class II molecules in binding toxic shock syndrome toxin 1 and determination of CD antigens expressed on T cells generated upon stimulation by the toxin.
Uchiyama T; Saito S; Inoko H; Yan XJ; Imanishi K; Araake M; Igarashi H
Infect Immun; 1990 Dec; 58(12):3877-82. PubMed ID: 2123824
[TBL] [Abstract][Full Text] [Related]
13. Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes.
Herrmann T; Accolla RS; MacDonald HR
Eur J Immunol; 1989 Nov; 19(11):2171-4. PubMed ID: 2599004
[TBL] [Abstract][Full Text] [Related]
14. Staphylococcal exotoxins deliver activation signals to human T-cell clones via major histocompatibility complex class II molecules.
Spertini F; Spits H; Geha RS
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7533-7. PubMed ID: 1881894
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents.
Dohlsten M; Hedlund G; Akerblom E; Lando PA; Kalland T
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9287-91. PubMed ID: 1924393
[TBL] [Abstract][Full Text] [Related]
16. Bacterial superantigen signaling via HLA class II on human B lymphocytes.
Mooney NA; Ju L; Brick-Ghannam C; Charron DJ
Mol Immunol; 1994 Jun; 31(9):675-81. PubMed ID: 8028602
[TBL] [Abstract][Full Text] [Related]
17. Binding sites for bacterial and endogenous retroviral superantigens can be dissociated on major histocompatibility complex class II molecules.
Thibodeau J; Labrecque N; Denis F; Huber BT; Sékaly RP
J Exp Med; 1994 Mar; 179(3):1029-34. PubMed ID: 8113671
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
[TBL] [Abstract][Full Text] [Related]
19. The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1.
Karp DR; Teletski CL; Scholl P; Geha R; Long EO
Nature; 1990 Aug; 346(6283):474-6. PubMed ID: 2377209
[TBL] [Abstract][Full Text] [Related]
20. Bacterial superantigens induce the proliferation of resting gamma/delta receptor bearing T cells.
Ramesh N; Horner A; Ahern D; Geha RS
Immunol Invest; 1995 Aug; 24(5):713-24. PubMed ID: 8543336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]